Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
Study NCT ID:
NCT00153933
Status:
COMPLETED
Last Update Posted:
2016-01-25
First Post:
2005-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-08
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
None
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-21
Last Update Post Date:
2016-01-25
Last Update Post Date Type:
ESTIMATED